Comparing Rare vs. Common Inflammatory Arthritis
Part of Bones, joints & muscles, Skin clinical trials.
This study compares rare inflammatory arthritis (from rare autoimmune diseases or drugs) to more common types (like rheumatoid arthritis). Researchers will look at tissue samples to understand the differences and help improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and able to give consent.
- You need arthritis or bursitis that is confirmed by ultrasound (showing swelling and blood flow).
- You may have a rare autoimmune disease or drug-related inflammation, OR a common type like rheumatoid arthritis or psoriatic arthritis.
- You cannot be on blood thinners (like warfarin, apixaban, or heparin).
- You must not have had biologic or targeted therapy (like JAK inhibitors) in the last 3 months (or rituximab in the last 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how early inflammatory joint diseases behave over time, especially early rheumatoid arthritis. It may help doctors better predict prognosis and tailor care for people with new symptoms.
This trial collects clinical and lab information (like blood and medical history) from people with rare autoimmune diseases, especially when symptoms are unusual. It aims to better understand what causes these illnesses and how newer treatments may help.
This study looks at how inflammatory “cytokines” are expressed in people with psoriasis—both those with joint involvement and those without. It may help researchers understand what drives joint disease and guide better future monitoring or treatments.
This study looks at how the immune system works in people with rare autoinflammatory diseases. The goal is to develop tests that can help doctors better understand and treat these conditions.
This study helps doctors better understand rare autoinflammatory diseases—conditions where the immune system mistakenly attacks the body—by collecting information from patients being treated at a major French hospital. Your participation could help improve how these diseases are diagnosed and managed.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
Hear when a new Inflammatory Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.